Coverage

Brighter

Brighter

Brighter strengthens its financing with 672 TSEK through exercise of warrants.

16:00 / 5 April 2018 Brighter Press release

The first exercise period for Brighter's warrants of series TO4 is now completed. The company thereby strengthens its financing with 672 TSEK, representing 111,770 new shares.

- Unfortunately, the reminder with the subscription note was sent late to the shareholders this subscription period, says Truls Sjöstedt, Brighter's CEO and founder. This combined with the fact that a few of the larger institutes involved did not send the notice of the offer as planned, resulted in a very low subscription rate. We are in communication with these institutes working to achieve better results in the future. The next period is the TO3 series subscription period that runs from 11th of April to 25thof April. We will also send out more information on that by mail to all holders.

The next period for subscribing shares using TO4s is 25th of August to 8th of September 2018.

Those who subscribed in this exercise period have now obtained Interim Shares. Once the registration has been completed with the Swedish Companies Registration Office, conversion of the interim shares will automatically take place without further notice to the holders. The conversion is expected to occur within approximately one week from the completed registration. The interim shares will not be listed for trading.

Through this warrant exercise the number of shares and votes in Brighter will increase by 111,770 shares to a total of 66,160,000.

For terms and conditions of the Warrants, please visit: http://brighter.se/en/investors/documents/. 

För ytterligare information, vänligen kontakta:

Truls Sjöstedt, CEO
Telefon: +46 709 73 46 00
E-post: truls.sjostedt@brighter.se

Ann Zetterberg, CFO
Telefon: +46 708 37 21 23 
E-post: ann.zetterberg@brighter.se

Om Brighter AB
Brighter är ett svenskgrundat företag som från en unik IP-portfölj skapar lösningar för vårdens största problem: att förändra beteendet hos patienter. Kroniska sjukdomar som diabetes ökar snabbt och står för allt större del av vårdkostnaderna globalt. Brighters affärsmodell bygger på att många särintressen skapar värde för varandra, så kallad Multi-Sided Market Platform. Genom ökad tillgänglighet till valid hälsodata skapar Brighter värde för alla intressenter inom vårdsektorn: patienter och närstående, vårdgivare, forskning, läkemedelsindustri och samhälle. www.brighter.se

Bolagets aktie är listad på NASDAQ OMX First North/BRIG (http://www.nasdaqomxnordic.com/shares/microsite?Instrument=SSE86375). Brighters Certified Adviser på NASDAQ OMX First North är Remium Nordic Holding AB, +46 (0)8 - 454 32 50, CorporateFinance@remium.com, www.remium.com.

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 16:00 CET on April 5, 2018.

Show as PDF

Show original from Cision

Cision

This information was distributed by Cision http://www.cisionwire.se/